DISARM
DISARM Disarming the silent threat of ovarian cancer Ovarian cancer (OC), a malignant tumour in one or both ovaries, is the most lethal of female gynecologic cancers in Europe. Often referred to as a “silent killer,” OC is typically diagnosed at an advanced stage due to its subtle, non-specific symptoms, and the lack of effective screening, underscoring the urgent need for improved early detection strategies. As one of the most heritable forms of cancer, with a significant proportion of cases linked to family history and genetic predisposition, OC also highlights the critical importance of multifactorial risk assessment tools to accurately identify high-risk individuals and enable targeted prevention. The DISARM project addresses these critical challenges of hereditary OC by advancing both multifactorial risk assessment and early detection through cutting-edge technologies. By…